Fidelity Disruptive Medicine ETF
FMED
11 hedge funds and large institutions have $29.7M invested in Fidelity Disruptive Medicine ETF in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
8% less funds holding
Funds holding: 12 → 11 (-1)
15.77% less ownership
Funds ownership: 68.19% → 52.41% (-16%)
31% less capital invested
Capital invested by funds: $42.8M → $29.7M (-$13.1M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$144K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.08K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$260 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$8.55M |
| 2 |
Jane Street
New York
|
-$996K |
| 3 |
BlackRock
New York
|
-$31.2K |
| 4 |
BW
BXM Wealth
Englewood,
Colorado
|
-$7.8K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$728 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $18M | -$728 | -28 | -0% |
|
|
2
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| $9.53M | -$8.55M | -328,596 | -46% |
|
|
3
Jane Street
New York
| $1.3M | -$996K | -38,308 | -42% |
|
|
VF
4
Virtu Financial
New York
| $343K | +$144K | +5,532 | +66% |
|
|
VT
5
Vise Technologies
New York
| $234K | – | – | – |
|
|
BW
6
BXM Wealth
Englewood,
Colorado
| $213K | -$7.8K | -300 | -3% |
|
|
GJIA
7
Glass Jacobson Investment Advisors
Owings Mills,
Maryland
| $31K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $5.67K | +$260 | +10 | +5% |
|
|
CPBTD
9
Central Pacific Bank - Trust Division
Honolulu,
Hawaii
| $2.38K | – | – | – |
|
|
GEA
10
Glen Eagle Advisors
Kingston,
New Jersey
| $2.21K | – | – | – |
|
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$2.08K | +80 | New |
|
|
12
BlackRock
New York
| – | -$31.2K | -1,154 | Closed |
|
|
QA
13
Quattro Advisors
Pittsburgh,
Pennsylvania
| – | -$48 | -2 | Closed |
|
FMED Hedge Fund Activity: Q1 2026 in Review
11 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q1 2026, worth a combined $29.7M — down 31% from $42.8M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of FMED and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.
The largest buyer was Virtu Financial, adding an estimated $144K. The largest seller was Wealth Enhancement Advisory Services, cutting an estimated $8.55M.
- 11 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q1 2026, down from 12 in Q4 2025.
- Funds reported $29.7M of Fidelity Disruptive Medicine ETF stock for Q1 2026, down 31% quarter-over-quarter.
- 1 fund opened new Fidelity Disruptive Medicine ETF positions in Q1 2026 and 2 closed out, a net change of -1 holder.
- The largest Fidelity Disruptive Medicine ETF buyer in Q1 2026 was Virtu Financial, an estimated $144K added.
- The largest Fidelity Disruptive Medicine ETF seller in Q1 2026 was Wealth Enhancement Advisory Services, an estimated $8.55M sold.
Based on aggregated 13F filings for Q1 2026.